Ampio Pharmaceuticals, Inc. [AMPE]

Source: 

Company Overview

Ampio Pharmaceuticals, Inc is a pre-revenue stage biopharmaceutical company. Until May 2022 we were focused on the clinical development of Ampion   and preclinical development of AR-300, a novel, proprietary, small molecule formulation that has (i) demonstrated anti-inflammatory properties in vitro and (ii) protection of cartilage in preclinical rat meniscal tear studies.